As was the case in the rest of the country, the COVID-19 pandemic dealt a severe blow to the tuberculosis (TB) response in the Free State. Refilwe Mochoari gathered the available numbers and asked the province’s health department about their plans to get the TB response back on track.
COVID-19 will continue to dominate headlines in 2022, but from National Health Insurance to the availability of a new HIV prevention injection, it will also be an important year for other areas of health service delivery and for health system governance and reforms. Here is Spotlight’s pick of the top ten issues to keep an eye on.
Whether it is in the queue outside a community healthcare clinic, in a GP’s waiting room, or in the ICU at a private sector hospital, infections acquired at healthcare facilities pose a threat to people’s health. Nthusang Lefafa looks at government’s recently relaunched infection prevention and control plans and some obstacles to its implementation.
It wasn’t rocket science when we predicted at the start of 2021 that South Africa’s biggest challenge this year would be to get COVID-19 shots into as many arms as possible. But the way it has played out with multiple setbacks and scrambling problem-solving is not something anyone could have predicted. In fewer than a thousand words, Spotlight editor Marcus Low takes a look back at a tumultuous year in health in South Africa.
The COVID-19 pandemic and associated lockdowns have dealt a severe blow to South Africa’s tuberculosis (TB) response. Tiyese Jeranji asked government about its plans to get TB diagnosis, treatment, and prevention services back on track.
Unlike regulators in the United States and Europe, the South African Health Products Regulatory Authority has not yet given the green light for any form of mix-and-match COVID-19 vaccine boosting. We take a look at the regulatory issues standing in the way of people in South Africa who received the Johnson & Johnson jab being offered Pfizer boosters.
There has been an increase in the number of acute psychiatric admissions in the Western Cape since June, adding to the existing pressure on bed capacity in the province’s hospitals. Tiyese Jeranji unpacks the numbers and the provincial health department’s plans to address them.
Although a new community healthcare monitoring report notes some improvement in filling vacancies at Gauteng clinics, concerns remain over staff shortages and the impact this has on providing quality care, especially to people living with HIV. Thabo Molelekwa reports.
Pharmaceutical companies Merck and Pfizer recently announced early results from clinical trials showing that two new antiviral medicines are highly effective in reducing COVID-19 deaths and hospitalisation. The Medicines Patent Pool then announced licensing deals with both companies that will allow for generic versions of the two drugs to be produced. Catherine Tomlinson unpacks the licenses and asks whether generic versions of these pills might now be made in Africa.
A UNAIDS report published earlier this year estimates that just under 4.5 million men and boys accessed voluntary male medical circumcision (VMMC) services in South Africa by the end of 2019 with 47% of these having been performed from 2016 to 2019. Thabo Molelekwa reports on the impact COVID-19 has had on VMMCs and the challenges related to resuming this service in the country.
In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.
Findings from a study conducted in Mqanduli in the Eastern Cape show the prevalence of stunting among children younger than five for that area was 24%. Luvuyo Mehlwana unpacks the findings and the plans the provincial health department has in place to address the risk factors driving stunting among children in the Eastern Cape.